Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Dishman Carbogen Amcis Ltd.
Change Company   
BSE Code 540701
ISIN Demat INE385W01011
Book Value 253.26
NSE Code DCAL
Dividend Yield % 0.00
Market Cap 34406.05
P/E 0.00
EPS -2.01
Face Value 2  
08-Oct-2025 Dishman Carbogen Amcis’ arm partners with Celonic...
17-Sep-2025 Dishman Carbogen Amcis submits revised investor ...
28-Aug-2025 Dishman Carbogen Amcis receives EIR from USFDA
28-Aug-2025 Dishman Carbogen Amcis rises on receiving EIR fro...
16-Jun-2025 USFDA completes inspection at Dishman Carbogen Am...
06-Jun-2025 Dishman Carbogen Amcis’ arm enters into co-invest...
26-May-2025 Dishman Carbogen Amcis informs about press release
22-Apr-2025 Dishman Carbogen Amcis’ arm gets drug manufacturi...
22-Apr-2025 Dishman Carbogen Amcis surges as its arm gets dru...
26-Mar-2025 Dishman Carbogen Amcis raises Rs 50 crore through...
20-Mar-2025 Dishman Carbogen Amcis’ arm receives Certificate ...
20-Mar-2025 Dishman Carbogen Amcis moves up as its arm receiv...
10-Jan-2025 Dishman Carbogen Amcis’ arm completes Swissmedic ...
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.